Segments - Italy Minimally Invasive Surgery Devices Market by Products (Handheld Instruments, Guiding Devices, Electrosurgical Devices, Endoscopic Devices, Laproscopic Devices, Robotic Assisted Surgical Systems, Ablation Devices, Laser Based Devices, and Others), Applications (Aesthetic, Cardiovascular, Gastrointestinal, Gynecological, Orthopedic, Urological, and Others), and Country - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The Italy Minimally Invasive Surgery Devices Market size was valued at USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031 expanding at a CAGR of 8.6% during 2023 – 2031. The growth of the market is attributed to the increasing prevalence of lifestyle-related and chronic disorders activities in the country.
Minimally invasive surgery, also known as minimally invasive procedures, have been enabled by the advancement in various medical technologies. Surgery by definition is invasive and many operations requiring incisions of some size are referred to as open surgery.
Minimally invasive surgery devices are utilized to treat medical conditions such as spinal and dental procedures, cardiac procedures, and aneurysms. These devices come with improvements in fiber-optics and image guidance. They also include enhancements in software systems and robotic components and are increasingly preferred in the healthcare industry.
For example, video-assisted thoracoscopic surgery (VATS) is performed for completely removal of an organ to treat trauma injuries. It is performed using a tube connected to a video camera that is inserted through the ribs through a small incision. The tube is called thoracoscope. Apart from imaging technology, virtual reality is becoming a major area of enhancement. Other procedures involving MIS surgical techniques include single-site laparoscopic surgery, spinal surgeries, cardiac, and needlescopic surgery.
According to the International Agency for Research on Cancer (IARC), the number of new incidences of cancer reported in Italy was 409,808 in 2018. Lung cancer is one of the leading causes of cancer deaths in men and women in Italy. The new incidences of lung cancer reported in Italy were 39,989. It is 9.8% of the total new cancer incidences in the country. This has increased the demand for effective treatment options with the rising lung cancer deaths and aging population.
The report on the Italy minimally invasive surgery devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Minimally Invasive Surgical Devices have revolutionized the way surgeries are performed, offering a less traumatic alternative to traditional open surgeries. These devices are designed to reduce the size of incisions required, thus minimizing the risk of infection and promoting quicker recovery times. In Italy, the adoption of these devices is on the rise, driven by the increasing demand for procedures that offer less post-operative pain and shorter hospital stays. The integration of advanced technologies such as robotics and enhanced imaging systems has further propelled the effectiveness of minimally invasive surgical devices, making them a preferred choice for both patients and healthcare providers.
|
Attributes |
Details The market for Minimally Invasive Surgery Devices in Italy is experiencing significant growth due to the rising awareness among patients about the benefits of these procedures. These devices not only offer precision and control but also ensure that patients experience minimal scarring and reduced recovery times. With advancements in surgical techniques and the introduction of innovative devices, healthcare professionals are now able to perform complex surgeries with greater accuracy and safety. This trend is expected to continue as more healthcare facilities in Italy invest in state-of-the-art minimally invasive surgery devices to enhance patient outcomes and streamline surgical processes. |
|
Report Title |
Minimally Invasive Surgery Devices Market - Italy Industry Analysis, Growth, Share, Size, Trends, and Forecast Minimally Invasive Thoracic Surgery is gaining traction in Italy as a preferred method for treating various thoracic conditions, including lung cancer and other chest-related ailments. This approach involves the use of specialized instruments and techniques to perform surgeries with minimal disruption to the body. The benefits of minimally invasive thoracic surgery include reduced pain, fewer complications, and faster recovery times, which are particularly important for patients with serious conditions such as cancer. As the prevalence of thoracic diseases continues to rise, the demand for minimally invasive thoracic surgery is expected to increase, driving further advancements and adoption of these techniques in the Italian healthcare system. |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Products (Handheld Instruments, Guiding Devices, Electrosurgical Devices, Endoscopic Devices, Laproscopic Devices, Robotic Assisted Surgical Systems, Ablation Devices, Laser Based Devices, and Others), and Applications (Aesthetic, Cardiovascular, Gastrointestinal, Gynecological, Orthopedic, Urological, and Others) |
|
Country Scope |
Italy |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast. |
|
Key Players Covered in the Report |
Medtronic Plc ;Terumo Corporation; Karl Storz GmbH; Olympus Corporation; GE Healthcare; Drägerwerk AG & Co.; KGaA; LED SpA; Fazzini and Quanta Systems. |
On the basis of products, the market is classified as handheld instruments, guiding devices, electrosurgical devices, endoscopic devices, laparoscopic devices, robotic assisted surgical systems, ablation devices, laser based devices, and others. The robotic assisted surgical systems segment is projected to expand at a considerable CAGR during the forecast period. Robotic assisted surgical systems are attributed to high efficiency and precision.
Gastrointestinal segment is anticipated to expand at a high CAGR
On the basis of applications, the minimally invasive surgery devices market is segregated into aesthetic, cardiovascular, gastrointestinal, gynecological, orthopedic, urological, and others. The gastrointestinal segment is projected to expand at a high CAGR during the forecast period. Rising rate of geriatric and pediatric gastroenterological disorders are some of the key factors driving the market growth Dyspepsia, irritable-bowel syndrome, and constipation are some of the examples of gastrointestinal disorders.
The Italy minimally invasive surgery devices market has been segmented on the basis of
The market is very competitive in nature owing to the presence of many major players. Some of the major players competing in the Italy minimally invasive surgery devices market are Medtronic Plc; Terumo Corporation; Karl Storz GmbH; Olympus Corporation; GE Healthcare; Drägerwerk AG & Co.; KGaA; LED SpA; Fazzini and Quanta Systems.
In December 2020, Abbott launched a minimally-invasive heart valve repair device in India to treat mitral regurgitation. It can assist with reestablishing the heart’s ability to pump oxygenated blood more productively and assist with further developing the organization's income.
In September 2020, Smith & Nephew announced the launch of HELOCOIL KNOTLESS suture anchor and improved its product portfolio in the line of advanced healing solutions for rotator cuff repair. This can assist the organization to increase its revenue in the coming years.
The gastrointestinal segment is expected to expand at a high CAGR, driven by the rising rates of geriatric and pediatric gastroenterological disorders such as dyspepsia, irritable-bowel syndrome, and constipation.
High installation costs of advanced surgical systems and devices can restrain market growth despite increasing demand.
Major companies include Medtronic Plc, Terumo Corporation, Karl Storz GmbH, Olympus Corporation, GE Healthcare, Drägerwerk AG & Co. KGaA, LED SpA, Fazzini, and Quanta Systems.
The increasing number of cancer cases, especially lung cancer, is driving demand for effective and less invasive treatment options, thereby boosting the market for minimally invasive surgery devices.
Major trends include advancements in fiber-optics, image guidance, software systems, robotic components, and the integration of virtual reality in surgical procedures.
The robotic assisted surgical systems segment is projected to expand at a considerable CAGR due to their high efficiency and precision.
These devices are used in aesthetic, cardiovascular, gastrointestinal, gynecological, orthopedic, urological, and other medical procedures.
The market includes handheld instruments, guiding devices, electrosurgical devices, endoscopic devices, laparoscopic devices, robotic assisted surgical systems, ablation devices, laser-based devices, and others.
Key drivers include the rising incidence of cancer and cardiovascular diseases, increasing development of minimally invasive procedures, growing demand for less painful surgical options, rapid adoption of advanced medical technologies, and supportive government initiatives.
The Italy Minimally Invasive Surgery Devices Market was valued at USD XX Billion in 2022 and is expected to reach USD XX Billion by 2031, expanding at a CAGR of 8.6% from 2023 to 2031.